Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Urinary biomarkers of exposure to the mycoestrogen zearalenone and its modified forms in German adults.

Ali N, Degen GH.

Arch Toxicol. 2018 Aug;92(8):2691-2700. doi: 10.1007/s00204-018-2261-5. Epub 2018 Jul 6.

PMID:
29980802
2.

Spectrophotometric Determination of RuBisCO Activity and Activation State in Leaf Extracts.

Sales CRG, Degen GE, da Silva AB, Carmo-Silva E.

Methods Mol Biol. 2018;1770:239-250. doi: 10.1007/978-1-4939-7786-4_14.

PMID:
29978406
3.

Increasing metabolic potential: C-fixation.

Andralojc PJ, Carmo-Silva E, Degen GE, Parry MAJ.

Essays Biochem. 2018 Apr 13;62(1):109-118. doi: 10.1042/EBC20170014. Print 2018 Apr 13. Review.

PMID:
29653967
4.

Blood plasma biomarkers of citrinin and ochratoxin A exposure in young adults in Bangladesh.

Ali N, Hossain K, Degen GH.

Mycotoxin Res. 2018 Mar;34(1):59-67. doi: 10.1007/s12550-017-0299-5. Epub 2017 Nov 16.

PMID:
29143924
5.

Preliminary data on citrinin kinetics in humans and their use to estimate citrinin exposure based on biomarkers.

Degen GH, Ali N, Gundert-Remy U.

Toxicol Lett. 2018 Jan 5;282:43-48. doi: 10.1016/j.toxlet.2017.10.006. Epub 2017 Oct 10.

PMID:
29030270
6.

Daily uptake of mycotoxins - TDI might not be protective for nursed infants.

Degen GH, Partosch F, Muñoz K, Gundert-Remy U.

Toxicol Lett. 2017 Aug 5;277:69-75. doi: 10.1016/j.toxlet.2017.06.002. Epub 2017 Jun 7.

PMID:
28602893
7.

[Mycotoxins in food : Occurrence, importance and health risk].

Degen GH.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jul;60(7):745-756. doi: 10.1007/s00103-017-2560-7. Review. German.

PMID:
28508953
8.

Ochratoxin A and its metabolites in urines of German adults-An assessment of variables in biomarker analysis.

Ali N, Muñoz K, Degen GH.

Toxicol Lett. 2017 Jun 5;275:19-26. doi: 10.1016/j.toxlet.2017.04.013. Epub 2017 Apr 23.

PMID:
28445738
9.

Biomonitoring of Mycotoxins in Urine: Pilot Study in Mill Workers.

Föllmann W, Ali N, Blaszkewicz M, Degen GH.

J Toxicol Environ Health A. 2016;79(22-23):1015-1025.

PMID:
27924714
10.

Determination of aflatoxin M1 in urine samples indicates frequent dietary exposure to aflatoxin B1 in the Bangladeshi population.

Ali N, Blaszkewicz M, Hossain K, Degen GH.

Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):271-281. doi: 10.1016/j.ijheh.2016.11.002. Epub 2016 Nov 10.

PMID:
27914868
11.

Evidence of ochratoxin A conjugates in urine samples from infants and adults.

Muñoz K, Cramer B, Dopstadt J, Humpf HU, Degen GH.

Mycotoxin Res. 2017 Feb;33(1):39-47. doi: 10.1007/s12550-016-0261-y. Epub 2016 Nov 9.

PMID:
27830509
12.

Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on Eco G+ in cosmetic products.

Scientific Committee on Consumer Safety (SCCS). Electronic address: sante-c2-SCCS@ec.europa.eu, Degen GH.

Regul Toxicol Pharmacol. 2016 Dec;82:157. doi: 10.1016/j.yrtph.2016.11.006. Epub 2016 Nov 4.

PMID:
27825836
13.

Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement.

Solecki R, Kortenkamp A, Bergman Å, Chahoud I, Degen GH, Dietrich D, Greim H, Håkansson H, Hass U, Husoy T, Jacobs M, Jobling S, Mantovani A, Marx-Stoelting P, Piersma A, Ritz V, Slama R, Stahlmann R, van den Berg M, Zoeller RT, Boobis AR.

Arch Toxicol. 2017 Feb;91(2):1001-1006. doi: 10.1007/s00204-016-1866-9. Epub 2016 Oct 6.

14.

Biomonitoring of Mycotoxins in Human Breast Milk: Current State and Future Perspectives.

Warth B, Braun D, Ezekiel CN, Turner PC, Degen GH, Marko D.

Chem Res Toxicol. 2016 Jul 18;29(7):1087-97. doi: 10.1021/acs.chemrestox.6b00125. Epub 2016 Jun 28.

15.

Assessment of deoxynivalenol exposure among Bangladeshi and German adults by a biomarker-based approach.

Ali N, Blaszkewicz M, Degen GH.

Toxicol Lett. 2016 Sep 6;258:20-28. doi: 10.1016/j.toxlet.2016.06.006. Epub 2016 Jun 22.

PMID:
27298273
16.

Response to “The Path Forward on Endocrine Disruptors Requires Focus”.

Autrup H, Barile F, Blaauboer BJ, Degen GH, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler JG, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Vermeulen NP.

Toxicol Sci. 2016 Feb;149(2):273-4. No abstract available.

PMID:
27213197
17.

Biomonitoring of concurrent exposure to ochratoxin A and citrinin in pregnant women in Bangladesh.

Ali N, Blaszkewicz M, Manirujjaman M, Degen GH.

Mycotoxin Res. 2016 Aug;32(3):163-72. doi: 10.1007/s12550-016-0251-0. Epub 2016 May 17.

PMID:
27185052
18.

Biomonitoring of the mycotoxin Zearalenone: current state-of-the art and application to human exposure assessment.

Mally A, Solfrizzo M, Degen GH.

Arch Toxicol. 2016 Jun;90(6):1281-92. doi: 10.1007/s00204-016-1704-0. Epub 2016 Mar 31. Review.

PMID:
27034246
19.

Urinary biomarkers of ochratoxin A and citrinin exposure in two Bangladeshi cohorts: follow-up study on regional and seasonal influences.

Ali N, Blaszkewicz M, Alim A, Hossain K, Degen GH.

Arch Toxicol. 2016 Nov;90(11):2683-2697. Epub 2015 Dec 26.

PMID:
26705708
20.

Opinion of the Scientific Committee on Consumer safety (SCCS)--Opinion on the safety of the use of α-arbutin in cosmetic products.

Sccs, Degen GH.

Regul Toxicol Pharmacol. 2016 Feb;74:75-6. doi: 10.1016/j.yrtph.2015.11.008. Epub 2015 Dec 2.

PMID:
26646661
21.

Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of the use of deoxyarbutin in cosmetic products.

Sccs, Degen GH.

Regul Toxicol Pharmacol. 2016 Feb;74:77-8. doi: 10.1016/j.yrtph.2015.11.007. Epub 2015 Dec 2.

PMID:
26646660
22.

Are we ready to estimate daily ochratoxin A intake based on urinary concentrations?

Degen GH.

Environ Int. 2016 Dec;97:254-255. doi: 10.1016/j.envint.2015.10.010. Epub 2015 Oct 24. No abstract available.

PMID:
26602605
23.

Highlight report: metabolism and toxicity by fumonisins.

Degen GH.

Arch Toxicol. 2015 Dec;89(12):2477-8. doi: 10.1007/s00204-015-1645-z. No abstract available.

PMID:
26597898
24.

Opinion of the Scientific Committee on Consumer Safety (SCCS)--Opinion on the safety of the use of β-arbutin in cosmetic products.

SCCS, Degen GH.

Regul Toxicol Pharmacol. 2015 Dec;73(3):866-7. doi: 10.1016/j.yrtph.2015.10.008. Epub 2015 Oct 19.

PMID:
26482403
25.

Deoxynivalenol Exposure Assessment for Pregnant Women in Bangladesh.

Ali N, Blaszkewicz M, Al Nahid A, Rahman M, Degen GH.

Toxins (Basel). 2015 Sep 24;7(10):3845-57. doi: 10.3390/toxins7103845.

26.

Occurrence of aflatoxin M1 in urines from rural and urban adult cohorts in Bangladesh.

Ali N, Hossain K, Blaszkewicz M, Rahman M, Mohanto NC, Alim A, Degen GH.

Arch Toxicol. 2016 Jul;90(7):1749-55. doi: 10.1007/s00204-015-1601-y. Epub 2015 Sep 21.

PMID:
26391179
27.

Toxicology: a discipline in need of academic anchoring--the point of view of the German Society of Toxicology.

Gundert-Remy U, Barth H, Bürkle A, Degen GH, Landsiedel R.

Arch Toxicol. 2015 Oct;89(10):1881-93. doi: 10.1007/s00204-015-1577-7. Epub 2015 Aug 28.

28.

Principles of Pharmacology and Toxicology Also Govern Effects of Chemicals on the Endocrine System.

Autrup H, Barile FA, Blaauboer BJ, Degen GH, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler JG, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Vermeulen NP.

Toxicol Sci. 2015 Jul;146(1):11-5. doi: 10.1093/toxsci/kfv082. Epub 2015 May 30.

PMID:
26026993
29.

A comparative study of the human urinary mycotoxin excretion patterns in Bangladesh, Germany, and Haiti using a rapid and sensitive LC-MS/MS approach.

Gerding J, Ali N, Schwartzbord J, Cramer B, Brown DL, Degen GH, Humpf HU.

Mycotoxin Res. 2015 Aug;31(3):127-36. doi: 10.1007/s12550-015-0223-9. Epub 2015 May 10.

PMID:
25957672
30.

Opinion of the Scientific Committee on Consumer Safety (SCCS)--The safety of the use of formaldehyde in nail hardeners.

Scientific Committee on Consumer Safety (SCCS), Bernauer U, Coenraads PJ, Degen GH, Dusinska M, Lilienblum W, Luch A, Nielsen E, Platzek T, Rastogi S, Rousselle C, van Benthem J, Bernard A, Giménez-Arnau AM, Vanhaecke T.

Regul Toxicol Pharmacol. 2015 Aug;72(3):658-9. doi: 10.1016/j.yrtph.2015.02.019. Epub 2015 Mar 27. No abstract available.

PMID:
25819931
31.

Multiplexed tracking of combinatorial genomic mutations in engineered cell populations.

Zeitoun RI, Garst AD, Degen GD, Pines G, Mansell TJ, Glebes TY, Boyle NR, Gill RT.

Nat Biotechnol. 2015 Jun;33(6):631-7. doi: 10.1038/nbt.3177. Epub 2015 Mar 23.

PMID:
25798935
32.

First results on citrinin biomarkers in urines from rural and urban cohorts in Bangladesh.

Ali N, Blaszkewicz M, Mohanto NC, Rahman M, Alim A, Hossain K, Degen GH.

Mycotoxin Res. 2015 Feb;31(1):9-16. doi: 10.1007/s12550-014-0217-z. Epub 2014 Dec 10.

PMID:
25488509
33.

Occurrence of the mycotoxin citrinin and its metabolite dihydrocitrinone in urines of German adults.

Ali N, Blaszkewicz M, Degen GH.

Arch Toxicol. 2015 Apr;89(4):573-8. doi: 10.1007/s00204-014-1363-y. Epub 2014 Sep 17.

PMID:
25224402
34.

Biomonitoring of ochratoxin A in blood plasma and exposure assessment of adult students in Bangladesh.

Ali N, Blaszkewicz M, Manirujjaman M, Perveen R, Al Nahid A, Mahmood S, Rahman M, Hossain K, Degen GH.

Mol Nutr Food Res. 2014 Nov;58(11):2219-25. doi: 10.1002/mnfr.201400403. Epub 2014 Sep 23.

PMID:
25164381
35.

Protective effect of boric acid on lead- and cadmium-induced genotoxicity in V79 cells.

Ustündağ A, Behm C, Föllmann W, Duydu Y, Degen GH.

Arch Toxicol. 2014 Jun;88(6):1281-9. doi: 10.1007/s00204-014-1235-5. Epub 2014 Apr 8.

PMID:
24710572
36.

Toxicity of the mycotoxin citrinin and its metabolite dihydrocitrinone and of mixtures of citrinin and ochratoxin A in vitro.

Föllmann W, Behm C, Degen GH.

Arch Toxicol. 2014 May;88(5):1097-107. doi: 10.1007/s00204-014-1216-8. Epub 2014 Feb 28.

PMID:
24577378
37.

Exposure of infants to ochratoxin A with breast milk.

Muñoz K, Blaszkewicz M, Campos V, Vega M, Degen GH.

Arch Toxicol. 2014 Mar;88(3):837-46. doi: 10.1007/s00204-013-1168-4. Epub 2013 Nov 23.

PMID:
24270973
38.

[Occurrence of the mycotoxin ochratoxin a in breast milk samples from Germany].

Muñoz K, Wollin KM, Kalhoff H, Degen GH.

Gesundheitswesen. 2013 Apr;75(4):194-7. doi: 10.1055/s-0033-1341442. Epub 2013 Apr 10. German. Erratum in: Gesundheitswesen. 2014 Sep;76(8-9):493.

PMID:
23576146
39.

Methods for analysis of citrinin in human blood and urine.

Blaszkewicz M, Muñoz K, Degen GH.

Arch Toxicol. 2013 Jun;87(6):1087-94. doi: 10.1007/s00204-013-1010-z. Epub 2013 Jan 25.

PMID:
23354378
40.

The metallohormone cadmium modulates AhR-associated gene expression in the small intestine of rats similar to ethinyl-estradiol.

Kluxen FM, Diel P, Höfer N, Becker E, Degen GH.

Arch Toxicol. 2013 Apr;87(4):633-43. doi: 10.1007/s00204-012-0971-7. Epub 2012 Nov 8.

PMID:
23135549
41.

Cytotoxic potency of mycotoxins in cultures of V79 lung fibroblast cells.

Behm C, Föllmann W, Degen GH.

J Toxicol Environ Health A. 2012;75(19-20):1226-31.

PMID:
22994576
42.

N-Acetylation of p-aminobenzoic acid and p-phenylenediamine in primary porcine urinary bladder epithelial cells and in the human urothelial cell line 5637.

Föllmann W, Blaszkewicz M, Behm C, Degen GH, Golka K.

J Toxicol Environ Health A. 2012;75(19-20):1206-15.

PMID:
22994574
43.

Analysis of ochratoxin A blood levels in bladder cancer cases and healthy persons from Pakistan.

Aslam M, Rivzi SA, Beg AE, Blaszkewicz M, Golka K, Degen GH.

J Toxicol Environ Health A. 2012;75(19-20):1176-84.

PMID:
22994571
44.

The rat prepubertal uterine myometrium and not the luminal epithelium is predominantly affected by a chronic dietary genistein exposure.

Möller FJ, Ledwig C, Zierau O, Hertrampf T, Degen GH, Diel P, Vollmer G.

Arch Toxicol. 2012 Dec;86(12):1899-910. doi: 10.1007/s00204-012-0907-2. Epub 2012 Jul 19.

PMID:
22811025
45.

Beyond overweight: nutrition as an important lifestyle factor influencing timing of puberty.

Cheng G, Buyken AE, Shi L, Karaolis-Danckert N, Kroke A, Wudy SA, Degen GH, Remer T.

Nutr Rev. 2012 Mar;70(3):133-52. doi: 10.1111/j.1753-4887.2011.00461.x. Epub 2012 Feb 15. Review.

PMID:
22364156
46.

Cadmium modulates expression of aryl hydrocarbon receptor-associated genes in rat uterus by interaction with the estrogen receptor.

Kluxen FM, Höfer N, Kretzschmar G, Degen GH, Diel P.

Arch Toxicol. 2012 Apr;86(4):591-601. doi: 10.1007/s00204-011-0787-x. Epub 2011 Nov 30.

PMID:
22127542
47.

Mycotoxin production by different ochratoxigenic Aspergillus and Penicillium species on coffee- and wheat-based media.

Muñoz K, Vega M, Rios G, Geisen R, Degen GH.

Mycotoxin Res. 2011 Nov;27(4):239-47. doi: 10.1007/s12550-011-0100-0. Epub 2011 May 17.

PMID:
23605925
48.

Urinary isoflavone phytoestrogens in German children and adolescents--a longitudinal examination in the DONALD cohort.

Degen GH, Blaszkewicz M, Shi L, Buyken AE, Remer T.

Mol Nutr Food Res. 2011 Mar;55(3):359-67. doi: 10.1002/mnfr.201000325. Epub 2010 Oct 11.

PMID:
20938994
49.

Relation of isoflavones and fiber intake in childhood to the timing of puberty.

Cheng G, Remer T, Prinz-Langenohl R, Blaszkewicz M, Degen GH, Buyken AE.

Am J Clin Nutr. 2010 Sep;92(3):556-64. doi: 10.3945/ajcn.2010.29394. Epub 2010 Jul 14.

PMID:
20631200
50.

The carcinogenicity debate on formaldehyde: How to derive safe exposure limits?

Bolt HM, Degen GH, Hengstler JG.

Arch Toxicol. 2010 Jun;84(6):421-2. doi: 10.1007/s00204-010-0561-5. No abstract available.

PMID:
20480361

Supplemental Content

Support Center